News

MS Research Australia Wins Outstanding Achievement Award in 2016

21 September 2016

MS Research Australia awarded the Australian Charity Awards Outstanding Achievement 2016

The Australian Business Awards (ABA) has recently announced its 2016 Australian Charity Award winners and MS Research Australia is proud to have won an Outstanding Achievement Award 2016 to go alongside winning the Charity of the Year Award in 2015.

The Australian Charity Award for Outstanding Achievement recognises charitable organisations that have achieved outstanding results through initiatives that have significantly benefited charitable causes. Initiatives are evaluated in accordance with the assessment framework and are scored across the key areas of Planning, Research and Development; Execution and/or Implementation; Impact and/or Outcomes and Performance Management.

In a sector that is more aligned with a “marathon” than a “sprint”, we are really proud of the small team at MS Research Australia and their incredible sustained effort. For many years, the team has worked long days, and for many, frequent late-night teleconferences with our global colleagues, to ensure that both our national and our increasingly global activities, are completed.

It has been wonderful to see the impact that multiple sclerosis (MS) research discoveries are now having for many people with MS. However there is still a considerable amount of work to be done, which will require all efforts to be doubled so that all potential research avenues are funded and translated into high impact and much needed improvements in the treatment, management and prevention of MS – ensuring the best quality of life for people affected by MS.

Our congratulations to the other award winners and especially to Cure Brain Cancer Australia, the worthy recipient of the 2016 Charity of the Year Award.

Related News

Media Release

Early results show world-first adaptive trial in action for progressive MS

17 September 2026

A potential treatment for progressive multiple sclerosis (MS) will continue in a world-first multi-arm, multi-stage adaptive trial after showing encouraging early signs, with recruitment set to expand across Australia.

MS News

Alpha lipoic acid shows promise in Stage 1 of Octopus trial in progressive MS

17 September 2026

Results from Stage 1 of the Octopus trial find one of the trial treatments, alpha lipoic acid, shows promise in progressive MS and will continue into trial Stage 2.

MS News

Women and MS: one of the disease’s biggest mysteries

9 September 2026

Why does MS affect women more often than men? How does female biology impact MS activity? Discover what recent research is revealing about risk, hormones, immunity and EBV.

Read More
science

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

MS Research Australia Wins Outstanding Achievement Award in 2016